Search results for "VACCINATION"

showing 10 items of 660 documents

Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations

2021

Vector design and its characterization is an area of great interest in current vaccine research. In this article, we have formulated and characterized a multicompartmental lipopolyplex, which associates multiple liposomes and polyplexes in the same complex. These particles allow the simultaneous delivery of lipid or water-soluble antigens associated with genes to the same cell, in much higher amounts than conventional lipopolyplexes. The vector characterization and optimization were carried out using liposomes with entrapped carboxyfluorescein and adapted electrophoretic assays. Two types of lipopolyplexes (containing hydrophilic or lipophilic antigens) were employed to evaluate their inter…

liposomesFarmacologiaCelllcsh:RS1-441Pharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesArticlelipopolyplexeslcsh:Pharmacy and materia medicaImmune systemAntigenvaccinemedicinemelanomaVacunacióVector (molecular biology)Melanomamulticompartmental lipopolyplexesLiposomebiologyChemistryMelanoma021001 nanoscience & nanotechnologymedicine.disease0104 chemical sciencesVaccinationmedicine.anatomical_structureBiochemistrynon-viral gene transferbiology.proteinantitumor immunizationAntibody0210 nano-technologyPharmaceutics
researchProduct

French Vaccine Pass to the Test of the Constitutional Council: Some Considerations in the Light of the European Convention on Human Rights

2022

On 21 January 2022 the French Constitutional Council issued a ruling on the constitutionality of the law which aimed to make the access to a very large number of places subject to a vaccine pass. Firstly, the essay illustrates the main points of the ruling with a particular focus on the legal criteria which constituted the parameters used by the French Constitutional Council, including a short explanation of the legal provisions rejected. The article then analyses the most recent judgement of the European Court of Human Rights (ECtHR) which regarded mandatory vaccinations. Specifically, the judgment focuses on the recent case Vavři¹ka and Others v. the Czech Republic which explained the mai…

mandatory vaccinationessence of rightEuropean Court of Human Rightderogation in time of emergencySettore IUS/13 - Diritto Internazionalehealth pavaccine pa
researchProduct

B and T cell immune responses elicited by the BNT162b2 (Pfizer–BioNTech) COVID-19 vaccine in nursing home residents

2021

ABSTRACTObjectivesThe immunogenicity of the BNT162b2 COVID-19 vaccine is understudied in elderly people with comorbidities. We assessed SARS-CoV-2-S-targeted antibody and T cell responses following full vaccination in nursing home residents (NHR).MethodsWe recruited 60 NHR (44 female; median age, 87.5 years), of whom 10 had previously had COVID-19, and 18 healthy controls (15 female; median age, 48.5 years). Pre- and post-vaccination blood specimens were available for quantitation of total antibodies binding RBD and enumeration of SARS-CoV-2-S-reactive IFN-γ CD4+ and CD8+ T cells by flow cytometry.ResultsThe seroconversion rate in presumably SARS-CoV-2 naïve NHR (95.3%), either with or with…

medicine.diagnostic_testbiologybusiness.industryImmunogenicityT cellFlow cytometryVaccinationmedicine.anatomical_structureImmune systemImmunologybiology.proteinMedicineSeroconversionAntibodybusinessCD8
researchProduct

COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Ita…

2021

The coronavirus disease 2019 (COVID-19) pandemic has not finished yet, and the most promising option towards its ending is widespread vaccination. Because patients with inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC), often require immune-modifying treatment, which might increase the risk of opportunistic infection,1 their vaccination history for several infectious diseases is routinely checked, and when inadequate, vaccination is performed at diagnosis or ideally before immune suppressive treatment is started.1 However, IBD patients were not found to be at an increased risk of developing COVID-19 or of experiencing a more severe disease course.2

medicine.medical_specialty2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)IBDBrief Report - ClinicalInternal medicinemedicineHumansImmunology and AllergyIn patientAcademicSubjects/MED00260SARS-CoV-2business.industryVaccinationGastroenterologyCOVID-19Inflammatory Bowel DiseasesInflammatory Bowel DiseasesCOVID-19 Vaccines HumanVaccinationIBD Crohn Ulcerative Colitis Vaccination Covid 19 Sars-Cov 2COVID-19; COVID-19 vaccine; IBD; vaccine hesitancyvaccine hesitancybusinessCOVID-19 vaccineInflammatory Bowel Diseases
researchProduct

Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinant…

2021

To the Editors, We thank Drs. R. Mungmunpuntipantip and V. Wiwanitkit1 for their comment on our recently published article, “COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association”.

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)WillingneGastroenterologyMEDLINEHesitancyInflammatory Bowel DiseasesInflammatory Bowel DiseasesVaccinationInternal medicineImmunology and AllergyMedicineIn patientbusinessInflammatory Bowel Diseases
researchProduct

El Instituto Médico Valenciano y la difusión de la vacuna

2004

The Medical Valencian Institute promoted a campaign of smallpox free vaccination (1851- 1894) by means of humanized vaccine sent from England. It spread the vaccination for the whole Spain and published careful statistics of the vaccinations practised in the Bulletin of the Medical Valencian Institute. The National Institute of Vaccination (1871) did not recognize his labor and one denied to him the category of Provincial Institute of Vaccination.

medicine.medical_specialty:CIENCIAS DE LA VIDA::Inmunología ::Vacunas [UNESCO]lcsh:R131-687Valencianinstituto médico valencianoInstituto Nacional de VacunaciónHistory and Philosophy of Sciencelcsh:History of medicine. Medical expeditionsAZ20-999lcsh:AZ20-999medicineSmallpoxinstitut mèdic valenciàmedical valencian institute:HISTORIA::Historia por especialidades::Historia de la medicina [UNESCO]vaccination statisticsHistory of medicine. Medical expeditionsR131-687smallpox vaccineUNESCO::CIENCIAS DE LA VIDA::Inmunología ::Vacunasbusiness.industryestadístiques de vacunaciómedicine.disease:CIENCIAS MÉDICAS [UNESCO]lcsh:History of scholarship and learning. The humanitieslanguage.human_languageVaccinationFamily medicineUNESCO::HISTORIA::Historia por especialidades::Historia de la medicinaUNESCO::CIENCIAS MÉDICASlanguageHistory of scholarship and learning. The humanitiespigotavacuna antivariólicabusinessNational Institute of Vaccinationestadísticas de vacunaciónDemography
researchProduct

Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical…

2006

Acute otitis media (AOM) is the most common bacterial infectious disease among children. Vaccination is proposed to prevent otitis and several clinical trials were performed to assess the efficacy of pneumococcal vaccines. The way vaccine efficacy is analysed varies among trials. However, the clinical meaning of an estimate of vaccine effect and its statistical test depends on the applied statistical method. We aim to bring the meaning and validity of statistical trial results to the attention of researchers. We consider all methodological approaches for analysing vaccine efficacy applied in pneumococcal vaccination trials included in a recent Cochrane Review. We demonstrate how different m…

medicine.medical_specialtyAcute otitis mediaPneumococcal InfectionsPneumococcal VaccinesmedicineHumansIntensive care medicineChildRandomized Controlled Trials as TopicGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryMiddle ear diseasePublic Health Environmental and Occupational HealthInfantVaccine efficacyClinical trialVaccinationOtitis MediaInfectious DiseasesOtitisInfectious disease (medical specialty)Research DesignChild PreschoolPneumococcal vaccinationImmunologyMolecular Medicinemedicine.symptombusinessVaccine
researchProduct

The Child Health Care System in Italy

2016

Pediatric care in Italy has been based during the last 40 years on the increased awareness of the importance of meeting the psychosocial and developmental needs of children and of the role of families in promoting the health and well-being of their children. The pediatric health care system in Italy is part of the national health system. It is made up of 3 main levels of intervention: first access/primary care, secondary care/hospital care, and tertiary care based on specialty hospital care. This overview will also include a brief report on neonatal care, pediatric preventive health care, health service accreditation programs, and postgraduate training in pediatrics. The quality of the Ital…

medicine.medical_specialtyAdolescentChild Health ServicesvaccinationsHealth administration03 medical and health sciences0302 clinical medicineAmbulatory careNursingchildren030225 pediatricsHealth caremedicineHumans030212 general & internal medicinehospitalChildUnlicensed assistive personnelHealth policyHRHIShealth care systembusiness.industryPublic healthpublic healthInternational healthInfantpediatric carechildren careItalychildren care; hospital; public health; vaccinationsSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolPediatrics Perinatology and Child Healthbusiness
researchProduct

The seroepidemiology of pertussis in Australia during an epidemic period

2006

Studying the epidemiology of pertussis and impact of differing vaccine schedules is difficult because of differing methods of case ascertainment. The advent of internationally standardized serological diagnosis for recent infection has allowed comparison of age-specific pertussis infection among European countries and was applied in Australia at the time of a major national epidemic. In 1997 and 1998, a nationally representative serum bank using residual sera from diagnostic laboratories was established. Measurement of pertussis toxin (PT) IgG level was conducted by a reference laboratory using an enzyme-linked immunosorbent assay standardized for a number of European countries. A titre of …

medicine.medical_specialtyAdolescentWhooping CoughEpidemiologyVaccination scheduleReference laboratoryPertussis toxinBordetella pertussisSerologySeroepidemiologic StudiesEpidemiologymedicineHumansChildAustralia/epidemiology Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage AdolescentDiphtheria-Tetanus-Pertussis VaccineWhooping coughTransmission (medicine)business.industryAustraliaInfantmedicine.diseaseVaccinationInfectious DiseasesChild PreschoolPopulation SurveillanceImmunologybusinessResearch ArticleDemographyEpidemiology and Infection
researchProduct

Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review

2021

ABSTRACT Introduction The pandemic caused by the novel coronavirus disease 2019 (COVID‐19) has had an unprecedented impact on the overall health and the global economy. Vaccination is currently the most dependable strategy to end the pandemic, despite the slower‐than‐hoped‐for rollout, particularly for low‐to‐middle‐income countries, and the uncertain duration of protection afforded by vaccination. The spike protein of the virus (immunodominant antigen of the virus) is the main target of the approved and candidate SARS‐CoV‐2 vaccines. This protein binds to the ACE2 receptor of the host cell, initiating the entry of the virus into the cell and the chain of subsequent events ending to Acute R…

medicine.medical_specialtyAllergyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)ExacerbationReview ArticleDermatologyallergic reactionsmedicine.disease_causeSARS‐CoV‐2VirusAntigenCOVID‐19PandemicHypersensitivityHumansMedicineIntensive care medicineReview ArticlesCoronavirusbusiness.industryVaccinationCOVID-19cutaneous reactionsmedicine.diseaseVaccinationBNT162b2mRNA VaccinesbusinessJournal of Cosmetic Dermatology
researchProduct